Top

Published in:

23-02-2023 | Gastric Cancer | Original Contribution

Soybean product consumption decreases risk of gastric cancer: results from the Health Examinees Study

Authors: Woo-Kyoung Shin, Hwi-Won Lee, Dan Huang, Katherine De la Torre, Sukhong Min, Aesun Shin, Jong-koo Lee, Jung Eun Lee, Daehee Kang

Published in: European Journal of Nutrition | Issue 4/2023

Abstract

Background

Epidemiological findings on the association between soybean product consumption and gastric cancer risk remain inconsistent. We evaluated the relationship between soybean product consumption and the risk of gastric cancer in a prospective cohort study in Korea.

Methods

This prospective cohort study included a total of 139,267 participants aged 40–69 years from the Health Examinees-Gem (HEXA-G) study between 2004 and 2013. Information on cancer diagnosis was retrieved from the Korea Central Cancer Registry until 31 December 2018. Multivariate hazard ratios (HRs) and 95% of confidence intervals (CIs) for the risk of gastric cancer according to the consumption of soybean products were estimated using Cox proportional hazards models.

Results

A total of 767 incident cases of gastric cancer occurred over an average follow-up period of 9.21 years. We found that men who consumed two servings per week had 37% lower risk of gastric cancer compared with who consume those who almost never consumed (HR for tofu consumption of more than two servings/week vs. almost never consumed was 0.63 (95% CI 0.45, 0.89); p for trend = 0.04). Among men with a BMI of less than 25 kg/m², increased consumption of soybean paste (p for trend = 0.02) and tofu (HR 0.51 (95% CI 0.32, 0.82 for more than two servings/week vs. almost never consumed); p for trend = 0.01) was associated with decreased risk of gastric cancer.

Conclusion

Our results suggest that a high consumption of soybean products has a protective effect against gastric cancer.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492CrossRefPubMed

Hong S, Won Y-J, Park YR, Jung K-W, Kong H-J, Lee ES (2020) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat Off J Korean Cancer Assoc 52(2):335. https://doi.org/10.4143/crt.2020.206CrossRef

Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210CrossRefPubMed

Uemura N, Okamoto S, Yamamoto S et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784–789. https://doi.org/10.1056/NEJMoa001999CrossRefPubMed

González CA, Pera G, Agudo A et al (2003) Smoking and the risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 107(4):629–634. https://doi.org/10.1002/ijc.11426CrossRefPubMed

Duell EJ, Travier N, Lujan-Barroso L et al (2011) Alcohol consumption and gastric cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Am J Clin Nutr 94(5):1266–1275. https://doi.org/10.3945/ajcn.111.012351CrossRefPubMed

Tokui N, Yoshimura T, Fujino Y et al (2005) Dietary habits and stomach cancer risk in the JACC study. J Epidemiol. https://doi.org/10.2188/jea.15.S98CrossRefPubMedPubMedCentral

Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY (2002) Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97(4):531–535. https://doi.org/10.1002/ijc.10111CrossRefPubMed

Tsugane S, Sasazuki S, Kobayashi M, Sasaki S (2004) Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 90(1):128–134. https://doi.org/10.1038/sj.bjc.6601511CrossRefPubMedPubMedCentral

10.

van den Brandt PA, Botterweck AA, Goldbohm RA (2003) Salt intake, cured meat consumption, refrigerator use and stomach cancer incidence: a prospective cohort study (Netherlands). Cancer Causes Control 14(5):427–438. https://doi.org/10.1023/A:1024979314124CrossRefPubMed

11.

Larsson SC, Bergkvist L, Wolk A (2006) Processed meat consumption, dietary nitrosamines and stomach cancer risk in a cohort of Swedish women. Int J Cancer 119(4):915–919. https://doi.org/10.1002/ijc.21925CrossRefPubMed

12.

Korea Health Industry Development Institute. National food and nutrition statistics: based on 2018 Korea National Health and Nutrition Examination Survey. Korea Health Industry Development Institute, Osong, Korea. 2018. https://www.khidi.or.kr/kps/dhraStat/result4?menuId=MENU01655&gubun=&year=2018 (Accessed on 5, Jan 2021).

13.

Ko K-P, Park SK, Yang JJ et al (2013) Intake of soy products and other foods and gastric cancer risk: a prospective study. J Epidemiol. https://doi.org/10.2188/jea.JE20120232CrossRefPubMedPubMedCentral

14.

Wada K, Tsuji M, Tamura T et al (2015) Soy isoflavone intake and stomach cancer risk in J apan: From the T akayama study. Int J Cancer 137(4):885–892. https://doi.org/10.1002/ijc.29437CrossRefPubMed

15.

Umesawa M, Iso H, Fujino Y, Kikuchi S, Tamakoshi A (2016) Salty food preference and intake and risk of gastric cancer: the JACC study. J Epidemiol 26(2):92–97. https://doi.org/10.2188/jea.JE20150023CrossRefPubMedPubMedCentral

16.

Health Examinees Study Group (2015) The health examinees (hexa) study: rationale, study design and baseline characteristics. Asian Pac J Cancer Prev 16(4):1591. https://doi.org/10.7314/apjcp.2015.16.4.1591CrossRefPubMed

17.

Kim Y, Han BG, the KoGES Group (2017) Cohort profile: the Korean genome and epidemiology study (KoGES) consortiu. Int J Epidemiol. https://doi.org/10.1093/ije/dyv316CrossRefPubMedPubMedCentral

18.

Shin S, Lee H-W, Kim CE et al (2017) Egg consumption and risk of metabolic syndrome in Korean adults: results from the health examinees study. Nutrients 9(7):687. https://doi.org/10.3390/nu9070687CrossRefPubMedPubMedCentral

19.

Ahn Y, Kwon E, Shim J et al (2007) Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr 61(12):1435–1441. https://doi.org/10.1038/sj.ejcn.1602657CrossRefPubMed

20.

Korean Nutrition Society. Food Composition Table. In: Recommended dietary allowances for Koreans, 7th edition. Seoul: The Korean Nutrition Society. The Korean Nutrition Society Seoul. Korea. 2000.

21.

Kom EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145(1):72–80. https://doi.org/10.1093/oxfordjournals.aje.a009034CrossRef

22.

Kweon SS, Shu XO, Xiang Y et al (2013) Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population. J Nutr 143(11):1736–1742. https://doi.org/10.3945/jn.113.177675CrossRefPubMedPubMedCentral

23.

Sauvaget C, Lagarde F, Nagano J et al (2005) Lifestyle factors, radiation and gastric cancer in atomic-bomb survivors (Japan). Cancer Causes Control 16(7):773–780. https://doi.org/10.1007/s10552-005-5385-xCrossRefPubMed

24.

Hara A, Sasazuki S, Inoue M et al (2012) Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr 95(1):147–154. https://doi.org/10.3945/ajcn.111.020479CrossRefPubMed

25.

Seel D, Kawabata T, Nakamura M et al (1994) N-nitroso compounds in two nitrosated food products in southwest Korea. Food Chem Toxicol 32(12):1117–1123. https://doi.org/10.1016/0278-6915(94)90127-9CrossRefPubMed

26.

Sarkar FH, Li Y (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21(3–4):265–280. https://doi.org/10.1023/A:1021210910821CrossRefPubMed

27.

Liggins J, Bluck LJ, Runswick S et al (2000) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11(6):326–331. https://doi.org/10.1016/S0955-2863(00)00085-1CrossRefPubMed

28.

Tatsuta M, Iishi H, Baba M et al (1999) Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 80(3):396–399. https://doi.org/10.1002/(SICI)1097-0215(19990129)80:3%3c396CrossRefPubMed

29.

Zhou HB, Chen JM, Cai JT, Du Q, Wu CN (2008) Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J Gastroenterol: WJG 14(4):627. https://doi.org/10.3748/wjg.14.627CrossRefPubMedPubMedCentral

30.

Yanagihara K, Ito A, Toge T, Numoto M (1993) Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 53(23):5815–5821PubMed

31.

Verdrengh M, Collins LV, Bergin P, Tarkowski A (2004) Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect 6(1):86–92. https://doi.org/10.1016/j.micinf.2003.10.005CrossRefPubMed

32.

Mace TA, Ware MB, King SA et al (2019) Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function. Sci Rep 9(1):5068. https://doi.org/10.1038/s41598-019-41687-zCrossRefPubMedPubMedCentral

33.

Ma Y, Wu X, Giovanni V, Meng X (2017) Effects of soybean oligosaccharides on intestinal microbial communities and immune modulation in mice. Saudi J Biol Sci 24(1):114–121. https://doi.org/10.1016/j.sjbs.2016.09.004CrossRefPubMed

34.

Yang YG, Lindahl T, Barnes DE (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131(5):873–886. https://doi.org/10.1016/j.cell.2007.10.017CrossRefPubMed

35.

Mazumder B, Seshadri V, Fox PL (2003) Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28(2):91–98. https://doi.org/10.1016/S0968-0004(03)00002-1CrossRefPubMed

36.

Zhu H, Li X, Zhang X et al (2016) Polymorphisms in mismatch repair genes are associated with risk and microsatellite instability of gastric cancer, and interact with life exposures. Gene 579(1):52–57. https://doi.org/10.1016/j.gene.2015.12.050CrossRefPubMed

37.

Karsli-Ceppioglu S, Ngollo M, Adjakly M et al (2015) Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer? OMICS 19:209–219. https://doi.org/10.1089/omi.2014.0142CrossRefPubMed

38.

Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA (2007) Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut 56(11):1503–1511. https://doi.org/10.1136/gut.2006.116665CrossRefPubMedPubMedCentral

39.

Lindblad M, Rodríguez LAG, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16(3):285–294. https://doi.org/10.1007/s10552-004-3485-7CrossRefPubMed

40.

Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290(1):66–72CrossRefPubMed

41.

Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. https://doi.org/10.1038/nrc1408CrossRefPubMed

42.

Furukawa H, Iwanaga T, Koyama H, Taniguchi H (1982) Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 42(12):5181–5182PubMed

43.

Singh S, Poulsom R, Wright N, Sheppard M, Langman M (1997) Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer. Gut 40(4):516–520. https://doi.org/10.1136/gut.40.4.516CrossRefPubMedPubMedCentral

44.

Pfeilschifter J, Köditz R, Pfohl M, Schatz H (2002) Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23(1):90–119. https://doi.org/10.1210/edrv.23.1.0456CrossRefPubMed

45.

Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117(1):60–69. https://doi.org/10.1172/JCI30111CrossRefPubMed

46.

Ko KP, Park SK, Park B et al (2010) Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean multicenter cancer cohort. Cancer Epidemiol Biomark Prev 19(5):1292–1300. https://doi.org/10.1158/1055-9965.EPI-09-1004CrossRef

47.

Chun OK, Chung SJ, Song WO (2009) Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 109(2):245–254. https://doi.org/10.1016/j.jada.2008.10.055CrossRefPubMed

48.

González CA, Pera G, Agudo A et al (2006) Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European prospective investigation into cancer and nutrition (EPIC–EURGAST). Int J Cancer 118(10):2559–2566. https://doi.org/10.1002/ijc.21678CrossRefPubMed

49.

Lee SA, Kang D, Shim K et al (2003) Original article effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 13(3):162–168. https://doi.org/10.2188/jea.13.162CrossRefPubMed

Title: Soybean product consumption decreases risk of gastric cancer: results from the Health Examinees Study
Authors: Woo-Kyoung Shin
Hwi-Won Lee
Dan Huang
Katherine De la Torre
Sukhong Min
Aesun Shin
Jong-koo Lee
Jung Eun Lee
Daehee Kang
Publication date: 23-02-2023
Publisher: Springer Berlin Heidelberg
Keywords: Gastric Cancer
Gastric Cancer
Published in: European Journal of Nutrition / Issue 4/2023
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-023-03115-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2023

Association between an oxidative balance score and mortality: a prospective analysis in the SUN cohort

Effect of reduced-calcium and high-calcium cheddar cheese consumption on the excretion of faecal fat: a 2-week cross-over dietary intervention study

Dietary patterns and young adult body mass change: A 9-year longitudinal study

Long-term dietary nitrate supplementation slows the progression of established atherosclerosis in ApoE−/− mice fed a high fat diet

Skeletal muscle and erythrocyte redox status is associated with dietary cysteine intake and physical fitness in healthy young physically active men

Long-term dietary DHA intervention prevents telomere attrition and lipid disturbance in telomerase-deficient male mice

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage